AVITA Medical Shows RECELL GO Success in 17 UK Burn Patients and ANZ Clearance
RCEL•AVITA Medical presented first UK clinical data on RECELL GO in 17 burn and reconstructive surgery patients at Stoke Mandeville Hospital, reporting complete graft take and uncomplicated donor-site healing. The CE-marked system recently gained regulatory authorization in Australia and New Zealand, streamlining skin-cell preparation and improving operating room workflow.
1. UK Clinical Data Presentation
AVITA Medical unveiled the first UK case series of its RECELL GO automated cell-harvesting device at the British Burn Association Annual Meeting. Investigators at Stoke Mandeville Hospital treated 17 burn and reconstructive surgery patients, achieving complete graft take, uncomplicated donor-site healing and successful discharges without complications.
2. Regulatory Milestones
RECELL GO obtained CE-mark certification in Europe and the UK in 2025 and has now secured regulatory authorization in Australia and New Zealand. These clearances pave the way for broader adoption of the system across Europe, the UK, Australia, New Zealand and other international markets.
3. Clinical and Workflow Advantages
Clinicians reported that RECELL GO standardized preparation of spray-on skin cells, reduced operator variability and freed clinical staff during processing. The automated system improved consistency of cell preparation and enhanced operating room efficiency, supporting faster, more predictable burn care procedures.
